OmniAb (OABI) Cash from Operations (2021 - 2026)
OmniAb's (OABI) quarterly Cash from Operations came in at 4914000.0 in Q1 2026, up 69.04% year-on-year from 2907007.38 in Q1 2025, and up 13.39% on a QoQ basis from 5674000.0 in Q4 2025.
OmniAb (OABI) Cash from Operations (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Cash from Operations data on file, last reported at 4914000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 69.04% year-over-year to 4914000.0 in Q1 2026; TTM through Mar 2026 was 25497000.0, a 33.78% increase from a year earlier, with the FY2025 full-year figure at 36455000.0, up 8.09% from the prior year.
- Cash from Operations for Q1 2026 stood at 4914000.0, up from 5674000.0 in the prior quarter.
- Over the last five years, Cash from Operations for OABI reached as high as 27688000.0 in Q1 2023 and fell as low as 17032000.0 in Q1 2024.
- Historically, Cash from Operations has averaged 4839588.24 across 5 years, with a median of 6198000.0 in 2023.
- Across the five-year window, Cash from Operations plunged 337.92% in 2022 and surged 137.87% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 7143000.0 in 2022, then dropped by 27.69% to 9121000.0 in 2023, then soared by 57.55% to 3872000.0 in 2024, then sank by 46.54% to 5674000.0 in 2025, then climbed by 13.39% to 4914000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 4914000.0 in Q1 2026, 5674000.0 in Q4 2025, and 9763000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | -4.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.91 Mn |
| Mar 31, 2026 | -4.91 Mn |
| Dec 31, 2025 | -5.67 Mn |
| Dec 31, 2025 | -5.67 Mn |
| Sep 30, 2025 | -9.76 Mn |
| Sep 30, 2025 | -9.76 Mn |
| Jun 30, 2025 | -5.15 Mn |
| Jun 30, 2025 | -5.15 Mn |
| Mar 31, 2025 | -15.87 Mn |
| Mar 31, 2025 | -15.87 Mn |
| Dec 31, 2024 | -3.87 Mn |
| Dec 31, 2024 | -3.87 Mn |
| Sep 30, 2024 | -6.58 Mn |
| Sep 30, 2024 | -6.58 Mn |
| Jun 30, 2024 | -12.18 Mn |
| Jun 30, 2024 | -12.18 Mn |
| Mar 31, 2024 | -17.03 Mn |
| Mar 31, 2024 | -17.03 Mn |
| Dec 31, 2023 | -9.12 Mn |
| Dec 31, 2023 | -9.12 Mn |